Trials / Completed
CompletedNCT01355146
Home Therapy With Replagal in Fabry Disease
Non Interventional Study of Replagal® Home Therapy in Patients With Fabry Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 127 (actual)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- 4 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to proof increasing patient satisfaction and preservation of quality of life in patients with Morbus Fabry disease receiving their Enzyme Replacement Therapy with Replagal (Agalsidase alfa) at home compared to receiving the infusions at the clinic or at doctor's practice.
Conditions
Timeline
- Start date
- 2011-03-15
- Primary completion
- 2017-09-30
- Completion
- 2017-09-30
- First posted
- 2011-05-17
- Last updated
- 2021-03-17
Locations
22 sites across 2 countries: Austria, Germany
Source: ClinicalTrials.gov record NCT01355146. Inclusion in this directory is not an endorsement.